South San Francisco, CA · Founded 2024 · Privately Held (backing)
Developer of innovative therapeutics designed to treat immune-mediated diseases by targeting underlying immune system dysfunction. Ouro Medicines is based in South San Francisco, CA and was founded in 2024. Its last reported valuation was $1.7 billion in Mar 2026. It has raised $120 million.
Last reported valuation
$1.7B
Oct 2026
Priced at
—
Total raised
$120.0M
Last round
—
Cap table — not yet on record
Ouro Medicines's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ouro Medicines with a free account
·Watch Ouro Medicines: the Monday email on marks, rounds and moves
